Guillaume Beltramo
Inserm · 135 works · 1,674 citations · h-index 21
Top works
- Haemoptysis in adults: a 5-year study using the French nationwide hospital administrative database
- Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study
- Pleuroparenchymal fibroelastosis as a late complication of chemotherapy agents
- Chronic respiratory diseases are predictors of severe outcome in COVID-19 hospitalised patients: a nationwide study
- Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial
- Pulmonary hypertension associated with ponatinib therapy
- CXCL10 could drive longer duration of mechanical ventilation during COVID-19 ARDS
- Usual interstitial pneumonia in ANCA-associated vasculitis: A poor prognostic factor
- The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome
- TRIM33 prevents pulmonary fibrosis by impairing TGF-β1 signalling
- Monitoring of noninvasive ventilation: comparative analysis of different strategies
- Pharmacological management of IPF
- Diffuse lung diseases ascribed to drugs: a nationwide observational study over 37 years using the French Pharmacovigilance Database
- CT features of interstitial lung disease in systemic lupus erythematosus and overlap lupus-other connective tissue disease
- Deglycosylated bleomycin has the antitumor activity of bleomycin without pulmonary toxicity
- Increasing burden of noninfectious lung disease in persons living with HIV: a 7-year study using the French nationwide hospital administrative database
- Adalimumab-induced interstitial pneumonia in patients with inflammatory bowel disease
- Characteristics and outcomes of gemcitabine-associated pulmonary hypertension
- High risk of lung cancer in surfactant-related gene variant carriers
- Daptomycin-induced eosinophilic pneumonia: Are there any risk factors?